Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only
Get Premium
TLPH Talphera Inc.
- Stocks
- Healthcare
- NASDAQ: TLPH
Price (delayed)
$0.4866
Market cap
$9.98M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$0.45
Enterprise value
$11.12M
acelrx pharmaceuticals inc. is a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of moderate-to-severe acute pain. the company’s product candidates, dsuvia™ (known
Highlights
TLPH's EPS is up by 47% year-on-year and by 10% since the previous quarter
TLPH's net income is up by 18% YoY and by 10% from the previous quarter
TLPH's gross profit has shrunk by 96% YoY
TLPH's revenue has shrunk by 96% YoY
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Website: http://www.acelrx.com
Key stats
What are the main financial stats of TLPH
Market
Valuations
Earnings
Shares outstanding
20.5M
Market cap
$9.98M
Enterprise value
$11.12M
Price to earnings (P/E)
N/A
Price to book (P/B)
1.49
Price to sales (P/S)
473.41
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
411.7
Revenue
$27,000
Gross profit
$27,000
Operating income
-$13.93M
Net income
-$11.64M
EBIT
-$11.64M
EBITDA
-$11.64M
Free cash flow
-$13.27M
Per share
Balance sheet
Liquidity
EPS
-$0.45
EPS diluted
-$0.45
Free cash flow per share
-$0.51
Book value per share
$0.33
Revenue per share
$0
TBVPS
$0.57
Total assets
$15M
Total liabilities
$9.4M
Debt
$6.53M
Equity
$5.6M
Working capital
$4.19M
Debt to equity
1.17
Current ratio
3.11
Quick ratio
2.71
Net debt/EBITDA
-0.1
Margins
Efficiency
Dividend
EBITDA margin
-43,122.2%
Gross margin
100%
Net margin
-43,122.2%
Operating margin
-51,596.3%
Return on assets
-58.9%
Return on equity
-129.5%
Return on invested capital
-83.5%
Return on capital employed
-89.5%
Return on sales
-43,122.2%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
TLPH stock price
How has the Talphera stock price performed over time
Intraday
2.21%
1 week
-1.18%
1 month
-9.03%
1 year
-52.76%
YTD
-7.16%
QTD
-1.7%
Financial performance
How have Talphera's revenue and profit performed over time
Revenue
$27,000
Gross profit
$27,000
Operating income
-$13.93M
Net income
-$11.64M
Gross margin
100%
Net margin
-43,122.2%
TLPH's gross profit has shrunk by 96% YoY
TLPH's revenue has shrunk by 96% YoY
TLPH's net income is up by 18% YoY and by 10% from the previous quarter
Talphera's operating income has increased by 12% YoY and by 9% QoQ
Price vs fundamentals
How does TLPH's price correlate with its fundamentals
Growth
What is Talphera's growth rate over time
Valuation
What is Talphera stock price valuation
P/E
N/A
P/B
1.49
P/S
473.41
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
411.7
TLPH's EPS is up by 47% year-on-year and by 10% since the previous quarter
TLPH's equity has plunged by 66% YoY and by 30% from the previous quarter
The P/B is 15% more than the last 4 quarters average of 1.3
TLPH's revenue has shrunk by 96% YoY
TLPH's price to sales (P/S) is 51% lower than its 5-year quarterly average of 965.8
Efficiency
How efficient is Talphera business performance
The company's return on invested capital rose by 38% YoY
The company's return on equity fell by 35% YoY and by 16% QoQ
TLPH's ROA is up by 7% year-on-year but it is down by 5% since the previous quarter
Dividends
What is TLPH's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for TLPH.
Financial health
How did Talphera financials performed over time
Talphera's total assets is 60% higher than its total liabilities
The quick ratio has dropped by 51% year-on-year and by 19% since the previous quarter
The company's current ratio fell by 48% YoY and by 13% QoQ
Talphera's debt is 17% more than its equity
The debt to equity has soared by 200% YoY and by 43% from the previous quarter
TLPH's equity has plunged by 66% YoY and by 30% from the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.